Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin M Bompiani

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Topics in Medicinal Chemistry|October 23, 2014
High-throughput screening technologies for botulinum neurotoxinsKristin M Bompiani, Tobin J Dickerson
Nucleic Acid Therapeutics|November 20, 2015
Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable AnticoagulantErin E Soule, Kristin M Bompiani, Rebecca S Woodruff, et al.
The Journal of Biological Chemistry|June 11, 2011
Distribution and biochemical properties of an M1-family aminopeptidase in Plasmodium falciparum indicate a role in vacuolar hemoglobin catabolismDaniel Ragheb, Seema Dalal, Kristin M Bompiani, et al.
Journal of Visualized Experiments : Jove|January 17, 2014
A high-throughput-compatible FRET-based platform for identification and characterization of botulinum neurotoxin light chain modulatorsDejan Caglič, Kristin M Bompiani, Michelle C Krutein, et al.
Metallomics : Integrated Biometal Science|May 10, 2016
Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivityKristin M Bompiani, Cheng-Yu Tsai, Felix P Achatz, et al.
Chemistry & Biology|July 29, 2014
Probing the coagulation pathway with aptamers identifies combinations that synergistically inhibit blood clot formationKristin M Bompiani, Jens L Lohrmann, George A Pitoc, et al.
RNA (New York, N.Y.)|October 23, 2009
Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombinShahid M Nimjee, Sabah Oney, Zoya Volovyk, et al.
Journal of the American Chemical Society|September 25, 2010
Weave tile architecture construction strategy for DNA nanotechnologyMajken N Hansen, Alex M Zhang, Abhijit Rangnekar, et al.
ACS Combinatorial Science|June 18, 2016
High-Throughput Screening Uncovers Novel Botulinum Neurotoxin Inhibitor ChemotypesKristin M Bompiani, Dejan Caglič, Michelle C Krutein, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 6, 2011
Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructuresAbhijit Rangnekar, Alex M Zhang, Susan Shiyuan Li, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|October 23, 2014
High-throughput screening technologies for botulinum neurotoxinsKristin M Bompiani, Tobin J Dickerson
Nucleic Acid Therapeutics|November 20, 2015
Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable AnticoagulantErin E Soule, Kristin M Bompiani, Rebecca S Woodruff, et al.
The Journal of Biological Chemistry|June 11, 2011
Distribution and biochemical properties of an M1-family aminopeptidase in Plasmodium falciparum indicate a role in vacuolar hemoglobin catabolismDaniel Ragheb, Seema Dalal, Kristin M Bompiani, et al.
Journal of Visualized Experiments : Jove|January 17, 2014
A high-throughput-compatible FRET-based platform for identification and characterization of botulinum neurotoxin light chain modulatorsDejan Caglič, Kristin M Bompiani, Michelle C Krutein, et al.
Metallomics : Integrated Biometal Science|May 10, 2016
Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivityKristin M Bompiani, Cheng-Yu Tsai, Felix P Achatz, et al.
Chemistry & Biology|July 29, 2014
Probing the coagulation pathway with aptamers identifies combinations that synergistically inhibit blood clot formationKristin M Bompiani, Jens L Lohrmann, George A Pitoc, et al.
RNA (New York, N.Y.)|October 23, 2009
Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombinShahid M Nimjee, Sabah Oney, Zoya Volovyk, et al.
Journal of the American Chemical Society|September 25, 2010
Weave tile architecture construction strategy for DNA nanotechnologyMajken N Hansen, Alex M Zhang, Abhijit Rangnekar, et al.
ACS Combinatorial Science|June 18, 2016
High-Throughput Screening Uncovers Novel Botulinum Neurotoxin Inhibitor ChemotypesKristin M Bompiani, Dejan Caglič, Michelle C Krutein, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 6, 2011
Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructuresAbhijit Rangnekar, Alex M Zhang, Susan Shiyuan Li, et al.
Pageof 2